14.09.2018 08:14:00

Medicover Acquires Leading Genetics Laboratory in Germany

STOCKHOLM, Sept. 14, 2018 /PRNewswire/ --

Medicover has signed an agreement to acquire the centre for genetic diagnostics of Dr. Klein, Dr. Rost and colleagues as well as its affiliate IMGM, both located in Martinsried, near Munich, Germany. The laboratory has a strong position within genetic testing, pathology, transfusion medicine, microbiology and virology and will accordingly enhance Medicover's offering within these areas. The acquisition will as well create a platform for further expansion in southern Germany.

Revenue for the laboratory amounted to around 17 million euro in 2017 with a total number of employees of 160. The transaction is subject to merger control clearance and regulatory approvals with closing expected in January 2019.

For further information, please contact:

Paula Treutiger, Corporate Communications and Investor Relations Director
+46-733-666-599
paula.treutiger@medicover.com

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/medicover/r/medicover-acquires-leading-genetics-laboratory-in-germany,c2617563

The following files are available for download:

http://mb.cision.com/Main/15662/2617563/908959.pdf

Meicover acquires leading genetics laboratory in Germany

 

Analysen zu Medicover AB Registered Shs -B-mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Medicover AB Registered Shs -B- 16,80 5,66% Medicover AB Registered Shs -B-